Jones Trading analyst Boris Peaker assumes coverage on IN8bio Inc. (NASDAQ: INAB) with a Buy rating and a price target of $5.00.

For an analyst ratings summary and ratings history on IN8bio Inc. click here. For more ratings news on IN8bio Inc. click here.

Shares of IN8bio Inc. closed at $1.44 yesterday.